• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.氯碳头孢与头孢克洛治疗女性尿路感染的比较。
Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.
2
Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.氯碳头孢与头孢克洛治疗膀胱炎和无症状菌尿症的对比
Clin Ther. 1992 Jan-Feb;14(1):54-63.
3
Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.氯碳头孢（LY163892）与头孢克洛治疗急性细菌性支气管炎的对比
Clin Ther. 1992 Jan-Feb;14(1):41-53.
4
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.氯碳头孢（LY163892）与头孢克洛治疗成年人群细菌性皮肤及皮肤结构感染的对比研究
Am J Med. 1992 Jun 22;92(6A):80S-85S. doi: 10.1016/0002-9343(92)90613-g.
5
Antibiotic therapy for urinary tract infections.
Am J Med. 1992 Jun 22;92(6A):95S-100S. doi: 10.1016/0002-9343(92)90615-i.
6
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.氯碳头孢（LY163892）与头孢克洛及诺氟沙星治疗单纯性肾盂肾炎的比较
Am J Med. 1992 Jun 22;92(6A):86S-94S. doi: 10.1016/0002-9343(92)90614-h.
7
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.头孢丙烯与头孢克洛治疗女性急性尿路感染的比较。
Antimicrob Agents Chemother. 1991 Sep;35(9):1940-2. doi: 10.1128/AAC.35.9.1940.
8
Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.头孢丙烯与头孢克洛治疗急性单纯性尿路感染的对比研究。头孢丙烯多中心研究组
Clin Ther. 1992 Mar-Apr;14(2):314-26.
9
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.头孢地尼与头孢克洛治疗单纯性尿路感染的对比研究
Clin Ther. 2000 Jul;22(7):818-25. doi: 10.1016/s0149-2918(00)80054-5.
10
Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.头孢丙烯与头孢克洛治疗急性单纯性尿路感染的疗效及安全性比较
J Antimicrob Chemother. 1991 Oct;28(4):581-6. doi: 10.1093/jac/28.4.581.

引用本文的文献

1
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.氯碳头孢。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1993 May;45(5):716-36. doi: 10.2165/00003495-199345050-00008.
2
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.头孢丙烯与头孢克洛治疗女性急性尿路感染的比较。
Antimicrob Agents Chemother. 1991 Sep;35(9):1940-2. doi: 10.1128/AAC.35.9.1940.

本文引用的文献

1
Maximum utilization of the life table method in analyzing survival.在分析生存情况时最大限度地利用生命表法。
J Chronic Dis. 1958 Dec;8(6):699-712. doi: 10.1016/0021-9681(58)90126-7.
2
Urinary tract infection caused by Staphylococcus saprophyticus.腐生葡萄球菌引起的尿路感染。
J Infect Dis. 1980 Oct;142(4):510-5. doi: 10.1093/infdis/142.4.510.
3
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.阿莫西林与克拉维酸联合治疗尿路感染
Antimicrob Agents Chemother. 1982 Oct;22(4):672-7. doi: 10.1128/AAC.22.4.672.
4
Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria.头孢氨苄治疗急性非复杂性尿路感染，特别提及抗体包被细菌。
Int J Clin Pharmacol Ther Toxicol. 1982 Mar;20(3):97-100.
5
Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.用甲氧苄啶与磺胺异恶唑治疗单纯性尿路感染，并特别提及抗体包被细菌和粪便菌群。
Antimicrob Agents Chemother. 1981 May;19(5):842-50. doi: 10.1128/AAC.19.5.842.
6
A comparison of cefaclor versus trimethoprim-sulfamethoxazole combination in the treatment of acute urinary infections.头孢克洛与甲氧苄啶-磺胺甲恶唑联合用药治疗急性泌尿系统感染的比较。
J Urol. 1981 Feb;125(2):228-9. doi: 10.1016/s0022-5347(17)54981-2.
7
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.阿莫西林-克拉维酸与头孢克洛治疗单纯性尿路感染的前瞻性比较
Antimicrob Agents Chemother. 1983 Nov;24(5):716-9. doi: 10.1128/AAC.24.5.716.
8
Antibiotic susceptibility testing by a standardized single disk method.采用标准化单纸片法进行抗生素敏感性试验。
Am J Clin Pathol. 1966 Apr;45(4):493-6.
9
API system: a multitube micromethod for identification of Enterobacteriaceae.API系统：一种用于鉴定肠杆菌科细菌的多管微量方法。
Appl Microbiol. 1972 Sep;24(3):449-52. doi: 10.1128/am.24.3.449-452.1972.
10
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.头孢呋辛酯治疗单纯性尿路感染：与头孢克洛和阿莫西林克拉维酸钾的比较。
Drugs Exp Clin Res. 1987;13(2):95-9.

氯碳头孢与头孢克洛治疗女性尿路感染的比较。

Loracarbef versus cefaclor in the treatment of urinary tract infections in women.

作者信息

Iravani A

机构信息

Department of Pediatrics, College of Medicine, University of Florida, Gainesville 32610-0296.

出版信息

Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.

DOI:10.1128/AAC.35.4.750
PMID:2069382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC245091/
Abstract

In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the loracarbef and cefaclor groups were 96 and 90%, respectively. Both loracarbef and cefaclor are safe, well tolerated, and effective in the treatment of urinary tract infections in women.

摘要

在一项双盲、前瞻性、随机研究中，108名患有急性尿路感染的大学女性被给予以下两种治疗方案，为期7天：每日一次服用200毫克氯碳头孢（LY163892）（n = 53），或每日三次服用250毫克头孢克洛（n = 55）。氯碳头孢组和头孢克洛组在治疗后5至9天的治愈率分别为96%和90%。氯碳头孢和头孢克洛在治疗女性尿路感染方面均安全、耐受性良好且有效。